Dawn Nowlin1, Patrick Bingham, Andrew Berridge
1Discovery Technologies-High Throughput Screening, La Jolla, USA. Dawn.Nowlin@pfizer.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Analyzing over 73,000 compounds from 63 high-throughput screening (HTS) campaigns reveals trends in active compounds. This process-centric view optimizes biological screening strategies and enhances drug discovery efforts.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: